Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 423 of 5804
-
New hope for AML patients: quizartinib maintenance trial launches
Disease control Recruiting nowThis clinical two-arm trial is designed to evaluate two doses of quizartinib as maintenance therapy after induction/consolidation in participants with FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) (+) acute myeloid leukemia (AML) in first complete remission …
Phase: PHASE2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Motorized brace aims to unload painful knees without surgery
Symptom relief Recruiting nowThe overall goal of this project is to establish a novel design and control paradigm for modular, partial-assist powered orthoses (exoskeletons) to enhance voluntary lower-limb motion and manage pain in broad patient populations. Building upon a previous study period that address…
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Can a modified interferon rein in early myelofibrosis?
Disease control OngoingThis is a phase 3 double-blind clinical trial arm to test Ropeginterferon alfa-2b (P1101) in adult patients with Primary Myelofibrosis (PMF) at early stage or low to medium risk. Participants will receive the study drug/placebo bi-weekly and have an assessment visit every 4 week…
Phase: PHASE3 • Sponsor: PharmaEssentia • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug shows promise against rare eye cancer before liver surgery
Disease control Recruiting nowUveal melanoma (UM) is a rare type of melanoma, with an incidence of 4.4 cases per million in Europe each year. During recent years, different treatment approaches have been tested in patients with metastatic UM. Responses have been reported primarily with localized treatment in …
Phase: PHASE2 • Sponsor: Grupo Español Multidisciplinar de Melanoma • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New hope for Hard-to-Treat lymphoma: phase 3 trial launches
Disease control Recruiting nowThe main objective of this study is to evaluate the differences in objective response rate and overall survival between the Purinostat mesylate for injection and selinexor, as assessed by blinded independent central review (BICR), in patients with relapsed or refractory diffuse l…
Phase: PHASE3 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Disease control
Last updated Jun 26, 2026 19:14 UTC
-
Magic mushroom compound tested for Long-Term depression relief
Disease control ENROLLING_BY_INVITATIONThis is a long- term extension of the double-blind trials APPROACH (CYB003-002) and EMBRACE (CYB003-003). Its aim is to examine the safety and long-term efficacy of CYB003 in participants with MDD.
Phase: PHASE3 • Sponsor: Cybin IRL Limited • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Targeted drug takes aim at Hard-to-Treat lung cancer
Disease control OngoingThis is a global, multicenter, open-label study that aims to assess the efficacy and safety of zelenectide pevedotin in participants with previously treated NECTIN4-amplified advanced or metastatic non-small cell lung cancer (NSCLC) who have received at least one prior line of sy…
Phase: PHASE2 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Experimental cell therapy targets aggressive brain tumors
Disease control OngoingThis is an open-label phase 1 study to assess the safety, feasibility, pharmacokinetics and preliminary efficacy of autologous T cells co-expressing two CARs targeting the cryptic EGFR epitope 806 and IL13Ra2 (referred to as "CART-EGFR-IL13Ra2 cells") in patients with newly diagn…
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New MRI test could spare pancreatic cancer patients from needless surgery
Diagnosis Recruiting nowPancreatic cancer has a low survival rate largely due to late diagnosis and undetected liver metastases. Computed tomography (CT), the standard diagnostic tool, often misses occult metastases that are later discovered during surgery. Recent studies suggest that magnetic resonance…
Sponsor: Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
Brain stem cell implant trial offers new hope for Parkinson's
Disease control Recruiting nowThis clinical trial is designed to test the safety and tolerability of the study intervention, RNDP-001, which will be implanted into the brain of study participants during a surgical procedure.
Phase: PHASE1, PHASE2 • Sponsor: Kenai Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New vaccine targets 26 pneumococcal strains in early trial
⭐️ VACCINE ⭐️ CompletedThe purpose of this experiment is to evaluate the safety and immunogenicity of the 26 valent pneumococcal conjugate vaccine in the population aged 2 months and above.
Phase: PHASE1, PHASE2 • Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:01 UTC
-
Bladder cancer combo trial: could adding chemo to BCG keep tumors away?
Disease control Recruiting nowThis phase III trial compares the effect of adding gemcitabine to intravesical Bacillus Calmette Guerin (BCG) versus intravesical BCG alone in patients with non-muscle invasive bladder cancer that has come back after a period of improvement (recurrent). Gemcitabine is a chemother…
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New cocktail of drugs could shrink stomach tumors before surgery
Disease control Recruiting nowGEMINI-PeriOp GC study will assess the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity of novel agents or novel combinations as perioperative treatment in participants with locally advanced resectable gastric, gastroesophageal junction (GEJ), or es…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Hope for Alzheimer's agitation: new drug combo enters final testing
Symptom relief Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease.
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Could this drug slow Alzheimer's brain damage?
Disease control Recruiting nowResearchers want to know if the study treatment called MK-2214 works to slow certain changes in the brains of people with Alzheimer's disease (AD). AD is a type of dementia that can cause loss of memory, communication (such as speech), and decision-making skills. It can limit a p…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New app sends suicide prevention tools to teens in moments of crisis
Disease control OngoingDespite efforts to prevent suicide, US rates are climbing, and suicide is the second leading cause of death amongst youth. Digital tools, especially personal smartphones, are promising avenues to address these issues and can be used to increase engagement with effective intervent…
Phase: NA • Sponsor: Ksana Health • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New eye drug aims to restore vision in inflammatory swelling
Disease control Recruiting nowA Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants with Macular Edema Secondary to Inflammation (MESI)
Phase: PHASE3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug 611 aims to cut COPD attacks in chinese patients
Disease control Recruiting nowThe objective of the study was to evaluate the efficacy and safety of 611 in Chinese adults with moderate to severe COPD.
Phase: PHASE3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for hospital patients: drug may shield kidneys from harmful meds
Prevention Recruiting nowThe goal of this clinical trial is to repurpose cilastatin for preventing acute kidney injury (AKI) in hospitalized patients receiving nephrotoxic medications. The trial will evaluate the efficacy of the re-purposed drug. The main questions it aims to answer are: \- whether cil…
Phase: PHASE2 • Sponsor: Matthew James • Aim: Prevention
Last updated Jun 27, 2026 08:00 UTC
-
Could a common antibiotic boost Chemo's power against breast cancer?
Disease control Recruiting nowDespite modern surgical and medical treatments, breast cancer can re-occur and lead 20% of patients to death. During the last 20 years, pre-clinical studies have shown that treatment failures may be due to the presence of a sub-type of cancer cells, the cancer stem cells, which a…
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC